National Health (Weighted average disclosed price – April 2026 reduction day) Determination 2025
6Weighted average disclosed price for brands of pharmaceutical items in Schedule 1
Start here
Get a plain-English read of 6
Turn the raw legal text into a practical explanation grounded in National Health (Weighted average disclosed price – April 2026 reduction day) Determination 2025.
6 Weighted average disclosed price for brands of pharmaceutical items in Schedule 1
(a) For subsection 99ADB(4) of the Act, the weighted average disclosed price of a brand of pharmaceutical item specified in column 2 of an item in the table to Schedule 1 is the amount specified in column 3 of that table item.
(b) Subsection (a) applies in respect of a data collection period for a brand of pharmaceutical item ending on 30 September 2025.
Note: Paragraph 99ADH(1)(a) of the Act applies if, under section 99ADB, the Minister determines the weighted average disclosed price of a brand of a pharmaceutical item in respect of a data collection period for the brand.